Is SpaceX Stock a Buy Before Its First Earnings Report as a Public Company?

SpaceX’s first earnings report (expected early August) is viewed as likely to disappoint near-term expectations given a stretched valuation at ~118x last year’s revenue on a ~$2.2T market cap. The article highlights long-dated execution risk: AI (via the $60B Cursor acquisition) is a growth driver but currently the least profitable segment, while Starlink revenue growth slowed from 96.4% (2024) to 49.8% (last year). With shares already retreating after IPO excitement, the piece argues investors may want to wait for earnings and management’s outlook before buying.

Analysis

The key issue is not whether the platform has long-dated optionality; it is whether that optionality is already priced as if it were partially monetized. At this multiple, the stock needs a steady cadence of hard evidence — not just vision — or the market will start discounting the story at a lower terminal growth rate, which can drive a 15-25% de-rating quickly even if the underlying business is still healthy.

Near term, the first print is a credibility test for capital allocation. If the company channels fresh balance-sheet capacity into frontier projects before proving a visible payback path, free-cash-flow expectations can get pushed out and the valuation gap versus public AI infrastructure names widens. That is the core second-order risk: the market may begin to prefer real AI monetization today over speculative AI adjacency, which is more constructive for NVDA than for a story stock tied to future compute demand.

Over 1-3 months, the most important catalyst is not the reported numbers themselves but guidance specificity: backlog conversion, launch cadence, and any quantified AI revenue milestones. The contrarian risk is that investors underestimate how much the liquidity overhang and index inclusion can sustain the multiple after a strong debut; the short thesis only works if the company fails to convert narrative into measurable 2026-2027 economics. Falsifier: a material raise to forward revenue growth or evidence that the new capital accelerates monetization sooner than expected.

Key Decisions for Investors

• Avoid initiating a fresh long in SPCX into the first earnings event; if already long, use any post-print strength to trim until management gives measurable forward KPIs.
• If borrow is available, express the valuation-risk view with a 1-3 month SPCX put spread rather than outright short stock; target a 15-20% downside window, with the trade invalidated by strong forward guidance or accelerated monetization milestones.
• Relative value: long NVDA / short SPCX as a cleaner AI exposure pair. NVDA monetizes actual capex cycles today; SPCX is priced for distant optionality. Reassess if SPCX demonstrates near-term AI revenue with contract detail.
• Set a watch item for the first call on launch cadence and cash deployment. If management quantifies 2026-2027 revenue inflection or major signed demand, cover shorts immediately; absent that, the multiple likely compresses over the next 1-3 months.